Structural Modelling of Krüppel‐Like Factor 15 Zinc Finger Binding Domain to DNA Using AlphaFold 3.0: Potential Therapeutic Target for Type 2 Diabetes
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Anwar Mohammad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Diabetes Mellitus, Type 2, DNA, Zinc Fingers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait Foundation for the Advancement of Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Krüppel‐like factor 15 (KLF15) is a transcription factor contributing to the pathophysiology of multiple diseases, including metabolic syndromes. It is 416 residues long, with a C2H2‐type zinc finger (ZnF) domain that binds to GC‐rich regions regulating transcription. The role of KLF15 in glucogenesis and glucose level maintenance is well established. However, the DNA interaction mechanism at the atomic level remains unresolved. Here, we utilised computational structural biology tools to address this knowledge gap. The KLF15 ZnF–domain interacting with DNA was modelled with AlphaFold 3.0. Alanine substitution of the KLF15 ZnF domain–DNA complex revealed that residues K334A, R334A, Y332A and R392A significantly affect the binding affinities (ΔΔG) to DNA. To understand the conformational stability and dynamics of the KLF15 ZnF–domain complexes, 100‐ns molecular dynamics simulations were performed. Additionally, molecular mechanics‐generalised Born (MM/GBSA) surface area was utilised to calculate total binding energies. The binding energies of the wild‐type KLF15 ZnF domain (−94.0 ± 0.17 kcal/mol) demonstrated a more robust binding affinity to DNA than K334A (−30.4 ± 0.35 kcal/mol), R344A (−42.8 ± 0.37 kcal/mol), Y332A (−47.7 ± 0.42 kcal/mol) and R392A (−30.8 ± 0.30 kcal/mol). The findings highlighted the unstable dynamics of the alinine substituted resdiues that consequently reduce the binding free energy compared to the wild‐type KLF15 ZnF domain. In conclusion, the four identified residues are essential to recognise KLF15 ZnF DNA binding and can be considered potential hotspots for the therapeutics development for type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center (HSC), Kuwait University, Kuwait City, Kuwait.
- Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Department of Translation Research, Dasman Diabetes Institute, Kuwait City, Kuwait.
ORCID-Profile: Anwar Mohammad
Förderung
- Kuwait Foundation for the Advancement of Sciences
Zitieren
APA
Mohammad, A., Abubaker, J., Marafie, S. K., AlShawaf, E., Ali, H., & Al-Mulla, F. (2025). Structural Modelling of Krüppel‐Like Factor 15 Zinc Finger Binding Domain to DNA Using AlphaFold 3.0: Potential Therapeutic Target for Type 2 Diabetes. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70565
Vancouver
Mohammad A, Abubaker J, Marafie SK, AlShawaf E, Ali H, Al-Mulla F. Structural Modelling of Krüppel‐Like Factor 15 Zinc Finger Binding Domain to DNA Using AlphaFold 3.0: Potential Therapeutic Target for Type 2 Diabetes. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70565
BibTeX
@article{Mohammad2025,
author = {Mohammad, Anwar and Abubaker, Jehad and Marafie, Sulaiman K and AlShawaf, Eman and Ali, Hamad and Al-Mulla, Fahd},
title = {Structural Modelling of Krüppel‐Like Factor 15 Zinc Finger Binding Domain to DNA Using AlphaFold 3.0: Potential Therapeutic Target for Type 2 Diabetes},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70565}
}
EUVIMED